Kyle Policy Partners, LLC

06/17/2022

Patient concerns over ever-increasing costs are growing, especially when it comes to their health care. Morning Consult recently conducted a 50-state poll to collect data focusing on health care cost and affordability challenges, and the responses tell us a lot about what adults across the country believe policymakers should do to tackle these problems.

Among the findings, 88% of Americans across all 50 states agree that policymakers should prioritize lowering their out-of-pocket health care costs. When given two options, over 50% of those surveyed would rather see the out-of-pocket costs decrease rather than pay a lower monthly premium. Specifically, when it comes to actual solutions to lower out-of-pocket costs, 77% of those surveyed favor requiring health insurance companies and pharmacy benefit managers (PBMs) to share the savings they receive directly with patients at the pharmacy counter. Read the full details in our latest blog: https://onphr.ma/3MVP41J

03/04/2022

Interesting information re how Obamacare has failed many American families, and proposals to fix the problem.

02/22/2022

So, in this time of long waits for appointments, and many people without a primary care physician, the question remains how those who may be at risk for severe illness get one of the new treatments? After two years, is there any progress toward matching patients with treatment in a timely manner despite issues finding a doctor?

How are the newly authorized antiviral medicines different from previous COVID-19 treatments?

02/22/2022

Learn more about the Medicare Part B program.

02/09/2022

An example of why there must be total transparency on drug pricing. A program intended to help indigent patients instead becomes a profit mule for hospitals. This type of outrage needs to stop.

The 340B program was created to help vulnerable patients access medicines at safety-net hospitals and clinics. Unfortunately, the program has become largely unrecognizable as profit incentives have fueled rapid program expansion, often at the expense of patients’ wellbeing. For instance, despite receiving generous discounts from manufacturers on outpatient medicines, sometimes bringing down the price to just a penny, 340B hospitals turn around and mark-up prices for patients and insurers, often up to nearly 3.8x what they paid to acquire the medicine. How does that benefit patients? Learn more: https://onphr.ma/3oxUdUi

02/09/2022

The quality of health care you receive depends not solely on how much doctors are paid, but how that pay is determined. Is it according to volume, or quality?

Value-based care is part of the healthcare vernacular. Yet, 9% of health expenditures involve alternative payment methodologies. That needs to change.

02/07/2022

As this article points out, there are two great mysteries as re the Covid 19 pandemic. First, how and where did the virus originate, and secondly, why are so many governments around the world uninterested in uncovering the first great mystery?

Plenty of evidence points to it.

02/05/2022

Newly released data from the National Health Expenditures shows the true picture of health care spending in the United States versus what patients are asked to pay for out of pocket. Read the latest at https://onphr.ma/3gidzZ9

01/29/2022

Newly released data shows which states are contributing most to Medicaid’s burgeoning improper payment rate of more than 20%.

01/26/2022

Here’s a refresher on why the drug pricing provisions in the BBBA are bad policy.

01/24/2022

As we look to the future, we urge policymakers to examine the growing threat of AMR and advance solutions to this significant and growing public health threat.